Cancer Research Institute Announces 2026 Lloyd J. Old STARs: A $6.25 Million Investment in Immunotherapy’s Future
The Cancer Research Institute (CRI) has proudly unveiled the 2026 class of its prestigious Lloyd...
Knowledge and News for the Global Fight Against Cancer.
The Cancer Research Institute (CRI) has proudly unveiled the 2026 class of its prestigious Lloyd...
Copenhagen, Denmark — Leo Pharma A/S, a global leader in medical dermatology, has significantly expanded...
The American Childhood Cancer Organization (ACCO) has officially named four-year-old Rylee as a 2026 Ambassador,...
The trajectory of pediatric oncology has reached a critical juncture where the success of initial...
The national non-profit organization CureSearch for Children’s Cancer has announced the appointment of three veteran...
The global scientific community is in mourning following the passing of Dr. Susumu Tonegawa, a...
The biopharmaceutical landscape continues to evolve rapidly, marked by significant advancements in oncology, strategic collaborations...
BioMarin Pharmaceutical Inc. announced on August 18, 2026, the acquisition of Alesta Therapeutics, a Netherlands-based...
The landscape of pediatric oncology is often defined by a dichotomy of rapid medical advancement...
The landscape of pediatric oncology is undergoing a period of rapid transformation as the demand...